This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
CVS Health (CVS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $62.99, marking a +0.08% move from the previous day.
Is CVS Health (CVS) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why You Should Add Stryker (SYK) to Your Portfolio Now
by Zacks Equity Research
Stryker's (SYK) core Mako Platform has been consistently driving its top line.
Easy Investing Secrets to an Early Retirement - October 09, 2019
by Zacks Equity Research
Achieving the financial freedom to retire early is a dream for most, but making that dream a reality isn't as tricky as it sounds. If you are willing to make some serious lifestyle changes and sacrifices, it can be possible.
Walgreens Inks Retail Health Collaboration Deal With Novant
by Zacks Equity Research
This collaboration is in line with Walgreens' (WBA) commitment toward providing affordable and convenient healthcare facilities to residents of North Carolina.
CVS Health (CVS) Stock Moves -0.4%: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $61.99, moving -0.4% from the previous trading session.
Signs That Your Trading Will Ruin Your Retirement - October 07, 2019
by Zacks Equity Research
Achieving your retirement goals takes a much different investing approach than regular stock trading, from smartly managing risk to keeping emotions in check.
Why CVS Health (CVS) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Health Insurers Hope to Gain From Executive Order on Medicare
by Sapna Bagaria
President Trump's executive order with focus on Medicare Advantage will probably increase the participation of health insurers in the social benefit program.
LabCorp to Expand Hematology Suite With Sysmex America Deal
by Zacks Equity Research
LabCorp (LH) will get to use Sysmex' advanced XN-9100 system, which is a scalable, modular automation system.
Walgreens (WBA) Becomes Latest Retailer to Suspend Zantac Sales
by Christopher Vargas
Walgreens (WBA) announced today that they would be suspending the sales of Sanofi's (SNY) heartburn medication Zantac.
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $63.07, moving +1.59% from the previous trading session.
Rite Aid (RAD) Beats Q2 Earnings Estimates, Updates View
by Zacks Equity Research
Rite Aid (RAD) posts mixed second-quarter fiscal 2020 results. Further, management revises its view for the fiscal year.
Are Investors Undervaluing CVS Health (CVS) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Opioid Overdose Crisis in US Likely to Affect These 3 Stocks
by Sreyoshi Mukherjee
Increasing lawsuits against pharmaceutical companies are likely to impact retailers and distributors.
Pharmacies & Drug Stores Industry Boasts Bright Prospects
by Urmimala Biswas
The Retail - Pharmacies and Drug Stores industry witnesses heavy consolidation.
CVS Health (CVS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $63.35, marking a -1.48% move from the previous day.
Cigna Expands Health Care Exchange Offerings to New Markets
by Zacks Equity Research
Cigna (CI) expands the health care exchange plan to new regions beginning 2020 to enrich customer experience.
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $63.47, moving +0.06% from the previous trading session.
Zacks.com featured highlights include: Anixter International, CVS Health, AmerisourceBergen, AECOM and Best Buy
by Zacks Equity Research
Zacks.com featured highlights include: Anixter International, CVS Health, AmerisourceBergen, AECOM and Best Buy
Should Invesco Russell 1000 Equal Weight ETF (EQAL) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for EQAL
Here's How Cigna (CI) is Poised Amid Political Uncertainty
by Zacks Equity Research
Growth in health services, government business and international markets drive Cigna's (CI) stock.
5 Stocks in the Limelight After Recent Broker Rating Upgrade
by Maharathi Basu
Broker opinion acts as a valuable guide for investors while deciding their course of action on a particular stock.
Top Ranked Momentum Stocks to Buy for September 16th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, September 16th
Is Deep Value ETF (DVP) a Strong ETF Right Now?
by Sweta Killa
Smart Beta ETF report for DVP